Patent · US Active

Treatment of portal hypertension and restoration of liver function using L-ornithine phenylacetate

US11266620B2 · kind B2 · utility

1Cited by
37References
17Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 20, 2017
Grant dateMar 8, 2022
Priority date—
Expiry dateNov 20, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P29/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are methods of treating and/or preventing portal hypertension and/or restoring liver function using L-ornithine phenylacetate.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.